AI Portfolio Summary
In 2025 Q4, Carlyle Group Inc. maintained a portfolio of 20 distinct positions. The most significant new addition to the portfolio was Medline Inc, which now represents 66.65% of the total fund value. The fund also reduced its exposure to Spruce Biosciences I by 98.7%.
Total Positions
20
Quarter
2025 Q4
Top Holding
MDLN (66.7%)
Top 10 Concentration
99.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-20 of 20
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MDLN
Medline Inc
|
Healthcare | 66.65% | — |
#1
Prev: #—
|
10.0 | 215,303,036 | no change |
NEW
|
215,303,036 | $9,042,727,512 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SARO
Standardaero In...
|
Industrials | 32.27% | 96.05% |
#2
1
Prev: #1
|
10.0 | no change | no change |
P
S
|
152,673,891 | $4,378,687,194 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHAT
Phathom Pharmac...
|
Healthcare | 0.43% | 0.95% |
#3
Prev: #3
|
0.2 | no change | no change |
P
S
|
3,496,808 | $57,977,077 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PONY
Pony Ai Inc
|
Technology | 0.25% | 1.22% |
#4
2
Prev: #2
|
0.1 | no change | no change |
P
S
|
2,362,447 | $34,255,482 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INVH
Invitation Home...
|
Real Estate | 0.14% | 0.32% |
#5
Prev: #5
|
2.2 | 186,600 | 39.1% |
P
S
|
664,100 | $18,455,339 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GETY
Getty Images Ho...
|
Communication Services | 0.06% | 0.28% |
#6
Prev: #6
|
0.0 | no change | no change |
P
S
|
6,234,252 | $8,353,898 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CUBE
CubeSmart
|
Real Estate | 0.06% | 0.21% |
#7
Prev: #7
|
0.0 | no change | no change |
P
S
|
220,500 | $7,949,025 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QTTB
Q32 Bio Inc
|
Healthcare | 0.03% | 0.05% |
#8
4
Prev: #12
|
0.0 | no change | no change |
P
S
|
1,102,741 | $3,616,990 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRB
Spruce Bioscien...
|
Healthcare | 0.02% | 0.57% |
#9
5
Prev: #4
|
0.3 | -2,857,898 | -98.7% |
P
S
|
38,620 | $3,298,920 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FWRD
Forward Air Cor...
|
Industrials | 0.02% | 0.07% |
#10
2
Prev: #8
|
0.0 | no change | no change |
P
S
|
107,214 | $3,093,606 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JSPR
Jasper Therapeu...
|
Healthcare | 0.01% | 0.06% |
#11
2
Prev: #9
|
0.0 | no change | no change |
P
S
|
1,066,189 | $1,940,464 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACET
Adicet Bio Inc
|
Healthcare | 0.01% | 0.06% |
#12
2
Prev: #10
|
0.3 | -2,764,423 | -93.7% |
P
S
|
184,295 | $1,544,391 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNUT
Krispy Kreme In...
|
Consumer Defensive | 0.01% | 0.03% |
#13
Prev: #13
|
0.0 | no change | no change |
P
S
|
340,748 | $1,369,807 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OKUR
Onkure Therapeu...
|
Healthcare | 0.01% | 0.02% |
#14
1
Prev: #15
|
0.0 | no change | no change |
P
S
|
269,895 | $771,900 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NABL
N-able Inc
|
Technology | 0.01% | 0.02% |
#15
1
Prev: #16
|
0.0 | no change | no change |
P
S
|
93,732 | $701,115 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPWR
SunPower Inc
|
Technology | 0.01% | 0.05% |
#16
5
Prev: #11
|
0.2 | -825,812 | -65.6% |
P
S
|
433,158 | $680,058 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NCNA
Nucana Plc
|
Healthcare | 0.00% | 0.01% |
#17
Prev: #17
|
0.0 | no change | no change |
P
S
|
133,333 | $479,999 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HOOD
Robinhood Mkts ...
|
Financial Services | 0.00% | — |
#18
Prev: #—
|
2.0 | 3,376 | no change |
NEW
|
3,376 | $381,826 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
Spyre Therapeut...
|
Healthcare | 0.00% | — |
#19
Prev: #—
|
2.0 | 9,620 | no change |
NEW
|
9,620 | $315,055 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XCUR
Exicure Inc
|
Healthcare | 0.00% | 0.03% |
#20
6
Prev: #14
|
0.2 | -225,308 | -80.0% |
P
S
|
56,328 | $304,734 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-20 of 20 holdings